Cite
Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies
MLA
Li, Weiyu, et al. Comparison of Biopsy Under-Sampling and Annual Progression Using Hidden Markov Models to Learn from Prostate Cancer Active Surveillance Studies. Dec. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......325..a9ba8e477cf12be8d83f1380b01d925d&authtype=sso&custid=ns315887.
APA
Li, W., Denton, B. T., Nieboer, D., Carroll, P. R., Roobol, M. J., Morgan, T. M., & Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. (2020). Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies.
Chicago
Li, Weiyu, Brian T Denton, Daan Nieboer, Peter R Carroll, Monique J Roobol, Todd M Morgan, and Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. 2020. “Comparison of Biopsy Under-Sampling and Annual Progression Using Hidden Markov Models to Learn from Prostate Cancer Active Surveillance Studies,” December. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......325..a9ba8e477cf12be8d83f1380b01d925d&authtype=sso&custid=ns315887.